Chinese company Anke introduced a 1.5 T high-field tomograph to the Russian market
The Chinese manufacturer of medical imaging equipment Anke has introduced a magnetic resonance imaging (MRI) scanner under the SuperMark brand with a field induction of 1.5 T to the Russian market. Roszdravnadzor issued a registration certificate for a medical device on May 18, 2021, the holder of the RU is the Russian distributor of Anke medical equipment, the SM-Labservice company.
SuperMark 1.5 T has become the second high-field tomograph manufactured by a company from the PRC, registered in the Russian Federation, but now it remains the only one. In 2011, a Superscan 1.5 T tomograph manufactured by the Chinese Ningbo Xingaoyi Magnetism Co was registered by Technofor CJSC, however, the medical device was deprived of its permission to apply by decree of the Government of the Russian Federation No. 1416 of December 27, 2012.
As the owner of SM-Labservice, Eldar Kozhemov, explained to Vademecum, the estimated cost of SuperMark has not been disclosed, but it is planned to supply MRI to the Russian market at a discount to average market prices.
In February 2021, SM-Labservice received a registration certificate for a 64-slice computerized X-ray tomograph Anatom 64 in two models – Precision and Clarity; a model with a resolution of 128 slices is also registered with Roszdravnadzor.
Shenzhen Anke High-Tech Co is a US-China medical imaging equipment manufacturer founded by the PRC Academy of Sciences and Analogic Corporation in 1986. The company produces MRI, CT, ultrasound, injectors and other medical equipment, 10 thousand clinics and 400 veterinary centers around the world are Anke’s clients.
According to SPARK-Interfax, SM-Labservice LLC is 100% owned by Eldar Kozhemov. In 2020, the company raised 138 million rubles. In addition, Eldar Kozhemov owns 80% of the Russian representative office of Anke, LLC Anke Rus. According to the EIS in the field of procurement, since the beginning of 2021, the company has signed contracts for the supply of CT to the central regional hospitals of the Republic of Crimea, Rostov region, as well as the Ministry of Health of Tatarstan for a total of 194.3 million rubles.